Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Nalu Bio logo — Harnessing the power of the endocannabinoid system for a hea...

Nalu Bio

Harnessing the power of the endocannabinoid system for a healthier future

Founded 2019 United States San Francisco, United States 17 employees Series A Total: $12.25M Biotechnology, Health Care

General Information

Company Name Nalu Bio
Founded Year 2019
Location United States San Francisco, United States
Employees 17
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Nalu Bio . To contact Nalu Bio , visit nalubio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nalu Bio compare?

A PDF of Nalu Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nalu Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nalu Bio

Nalu Bio is a San Francisco-based biotech startup, with a mission to unlock the potential of cannabinoids for the betterment of humanity and the planet. Founded in 2019, the company is helmed by a female-led team. Nalu Bio leverages innovative chemistry and predictive AI modeling to address prevalent global health issues such as pain, anxiety, sleep disorders, and weight management, impacting an estimated 2 billion individuals worldwide. Their focus is on developing a proprietary pipeline of no-high, chemistry-derived cannabinoids, maintaining the molecular identity of the plant while overcoming drawbacks related to safety, predictability, scalability, and sustainability. These products are targeted for adoption by global CPG and therapeutics companies, ensuring effective, safe, and consistent products for sectors including food and beverage, health and wellness, and personal care. Their pipeline also includes therapeutic products designed to mimic naturally occurring cannabinoids, with the aim of creating new chemical entities (NCEs) that could potentially improve the druggability, safety, and efficacy of certain high-demand medications, while potentially reducing side effects. Nalu Bio's approach targets advancements in the biotechnology and healthcare sectors. The company has recently secured a significant $12.00M Series A investment on 28 February 2023, attracting support from prominent investors including Flybridge, Golden Seeds, Portfolia, Sacramento Angels, Axial VC, Brown Angel Group, Intrinsic Capital Partners, L37 Ventures, and Bonaventure Equity. In summary, Nalu Bio's innovative approach to harnessing the power of cannabinoids, combined with their recent substantial Series A investment, positions them as a potential game-changer in the biotech and healthcare industries. For more information, visit NaluBio.com or contact them at [email protected].

Business keywords: biotech company, cannabinoids, health and wellness, predictive AI modeling, chemistry-derived cannabinoids, therapeutics, minor cannabinoids, CPG industry, NCEs, health tech, San Francisco, female-founded, data-driven, personal care

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.00M 9
Flybridge Golden Seeds Portfolia
Flybridge, Golden Seeds +7
28 Feb 2023
Seed Round $250.00K 1
Newchip Accelerator
03 May 2022
Seed Round Undisclosed -
16 Sep 2021
Seed Round Undisclosed -
07 Jan 2021

Nalu Bio Alternatives & Competitors

Nalu Bio vs
Vizuri Health Sciences, LLC
Vizuri Health Sciences, LLC United States

Harnessing nature-inspired ingredients to help manage age-related diseases, empowering adults to enj...

2 employees
Biotechnology, Health Care

FAQ About Nalu Bio

Harnessing the power of the endocannabinoid system for a healthier future
Nalu Bio was founded in 2019.
Nalu Bio is headquartered in San Francisco, United States.
Nalu Bio operates in Biotechnology and Health Care. Its work centres on biotech company, cannabinoids, health and wellness and predictive AI modeling.
Nalu Bio has approximately 17 employees.
Nalu Bio has completed 4 funding rounds, raising a total of $12.25M. The latest funding stage is Series A.
Top alternatives and competitors to Nalu Bio include Vizuri Health Sciences, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nalu Bio and Vizuri Health Sciences, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nalu Bio , https://bouncewatch.com/company/nalu-bio, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout